UBI PHARMA INC has a total of 18 patent applications. Its first patent ever was published in 2013. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and pharmaceuticals are SYNIMMUNE GMBH, BIOMUNEX PHARMACEUTICALS and Numab Therapeutics AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Republic of Korea | 2 | |
#5 | Taiwan | 2 | |
#6 | United States | 2 | |
#7 | Brazil | 1 | |
#8 | China | 1 | |
#9 | Hong Kong | 1 | |
#10 | New Zealand | 1 | |
#11 | Singapore | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Peng Wen-Jiun | 14 |
#2 | Yang Shu-Ping | 7 |
#3 | Peng Hung-Chih | 7 |
#4 | Kao Wei-Ting | 7 |
#5 | Wang Chang-Yi | 7 |
#6 | Chen Yu-Hung | 7 |
#7 | Peng Wen Jiun | 3 |
#8 | Peng Hung Chih | 2 |
#9 | Chen Yu Hung | 2 |
#10 | Yang Shu Ping | 2 |
Publication | Filing date | Title |
---|---|---|
EP3307304A1 | Immunoglobulin fusion proteins and uses thereof | |
WO2016201244A1 | Immunoglobulin fusion proteins and uses thereof | |
US2016362473A1 | Immunoglobulin fusion proteins and uses thereof | |
KR20150085839A | Recombinant protein |